You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exenatide

Showing 401 - 425 of 425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Beijing (PEX168 or )

Completed
  • Type 2 Diabetes
  • PEX168 or placebo
  • Beijing, China
    China-Japan Friendship Hospital
Oct 15, 2013

Hyperlipidemia Trial in Toronto (exenatide)

Completed
  • Hyperlipidemia
  • exenatide
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jun 21, 2012

Type 2 Diabetes Trial in Chengdu (PEX168)

Completed
  • Type 2 Diabetes
  • Chengdu, China
    People's Liberation Army General Hospital of Chengdu Military Re
Oct 15, 2013

Type 2 Diabetes, Diabetes, Type 2 Trial (exenatide)

Completed
  • Type 2 Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • exenatide
  • (no location specified)
May 31, 2012

Myocardial Infarction Trial in Seoul (exenatide BYETTA® (Amylin-Lilly), Saline)

Completed
  • Myocardial Infarction
  • exenatide BYETTA® (Amylin-Lilly)
  • Saline
  • Seoul, Korea, Republic of
    Kyung Hee University Hospital
Apr 18, 2012

Parkinson's Disease Trial in London (Exenatide)

Unknown status
  • Parkinson's Disease
  • Exenatide
  • London, United Kingdom
    National Hospital for Neurology and Neurosurgery
Mar 22, 2012

Type 2 Diabetes Trial in Hayward (ITCA 650 60 mcg/day, glimepiride)

Withdrawn
  • Type 2 Diabetes
  • Hayward, California
    Intarcia Therapeutics, Inc
Dec 21, 2012

Type 2 Diabetes Trial in Hayward (ITCA 650, glimepiride)

Withdrawn
  • Type 2 Diabetes
  • Hayward, California
    Intarcia Therapeutics, Inc
Dec 21, 2012

Type 2 Diabetes Trial in Hayward (ITCA 650 60 mcg/day, sitagliptin)

Withdrawn
  • Type 2 Diabetes
  • Hayward, California
    Intarcia Therapeutics, Inc
Dec 21, 2012

Myocardial Infarction, Coronary Artery Diseases, Diabetes, Type 2 Trial in Almaty (Conventional treatment, Weight loss

Completed
  • Myocardial Infarction
  • +3 more
  • Conventional treatment
  • Weight loss treatment
  • Almaty, Kazakhstan
    Scientific Research Institute of Cardiology and Internal Disease
Oct 3, 2012

Diabetes, Type 2 Trial in Zuidlaren (MKC253 Inhalation Powder, Technosphere Inhalation Powder, subcutaneous injection)

Completed
  • Diabetes Mellitus, Type 2
  • MKC253 Inhalation Powder
  • +2 more
  • Zuidlaren, Netherlands
    University Medical Centre Groningen
Jun 12, 2012

Diabetes Type 2 Trial in Washington (Insulin-Levemir, Exenatide-Bayetta, Insulin-Levemir and Exenatide-Bayetta)

Completed
  • Diabetes Type 2
  • Washington, District of Columbia
  • +1 more
Jun 24, 2011

Type 2 Diabetes Trial in Aarhus (Byetta, Exenatide)

Completed
  • Type 2 Diabetes
  • Byetta, Exenatide
  • Aarhus, Aarhus C, Denmark
  • +2 more
Jun 29, 2011

Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI). Trial in

Unknown status
  • Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).
  • Exenatide infusion
  • Placebo infusion.
  • Amsterdam, Netherlands
    VU Medical Center
Dec 3, 2010

Nonalcoholic Fatty Liver Disease Trial in Bochum (Exenatide)

Completed
  • Nonalcoholic Fatty Liver Disease
  • Exenatide
  • Bochum, Germany
    Department of Medicine I; University Hospital St. Josef-Hospital
Sep 23, 2010

Type 2 Diabetes Trial in Peking (rExenatide-4)

Unknown status
  • Type 2 Diabetes
  • rExenatide-4
  • Peking, Beijing, China
    Peking University First Hospital
Apr 25, 2011

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin Lispro Protamine Suspension, Insulin Glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin Lispro Protamine Suspension
  • Insulin Glargine
  • Phoenix, Arizona
  • +51 more
Jan 12, 2011

Glucocorticoid-induced Glucometabolic Abnormalities, Glucocorticoid-induced Beta-cell Dysfunction Trial in Amsterdam (Placebo,

Completed
  • Glucocorticoid-induced Glucometabolic Abnormalities
  • Glucocorticoid-induced Beta-cell Dysfunction
  • Placebo
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jan 12, 2010

Type 2 Diabetes, Impaired Glucose Tolerance Trial in Phoenix (Exenatide, Normal Saline)

Completed
  • Type 2 Diabetes Mellitus
  • Impaired Glucose Tolerance
  • Exenatide
  • Normal Saline
  • Phoenix, Arizona
    Phoenix VA Medical Center
Sep 9, 2009

Type 2 Diabetes Trial in Neuss (insulin glargine + exenatide + preexisting metformin, insulin glargine + sitagliptin +

Completed
  • Type 2 Diabetes
  • insulin glargine + exenatide + preexisting metformin
  • +2 more
  • Neuss, Germany
    Profil Institut für Stoffwechselforschung GmbH
Sep 3, 2009

Type 2 Diabetes Trial in Brussels (exenatide (Byetta))

Completed
  • Type 2 Diabetes Mellitus
  • exenatide (Byetta)
  • Brussels, Brabant, Belgium
    Cliniques universitaires St-Luc
Jul 30, 2009

Morbid Obesity Trial in Bend (Exenatide, Placebo)

Unknown status
  • Morbid Obesity
  • Exenatide
  • Placebo
  • Bend, Oregon
  • +1 more
Mar 30, 2009

Type 2 Diabetes Trial in Miami, Orlando, Knoxville (BMS-686117, Byetta, Placebo)

Completed
  • Type 2 Diabetes
  • Miami, Florida
  • +2 more
Mar 13, 2009

Diabetes, Arterial Stiffness Trial in Zrifin (sitagliptin, glibenclamide)

Unknown status
  • Diabetes Mellitus
  • Arterial Stiffness
  • Zrifin, Israel
    Department of Internal Medicine A , Research & Development unit
Jun 12, 2008

Polycystic Ovary Syndrome Trial in Baton Rouge (metformin, exenatide or combined (metformin & exenatide ))

Completed
  • Polycystic Ovary Syndrome
  • metformin, exenatide or combined (metformin & exenatide )
  • Baton Rouge, Louisiana
    Facility: Metabolic Center of Louisiana Research Foundation
Jul 10, 2007